OraSure TechnologiesOSUR +1.25%57 Days Payable is 48.53 as of Mar. 2026, which is 3% above its 10-year median of 47.29. GuruFocus rates OSUR with a GF Score™ of 57/100 and a GF Value™ of $1.98 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 796 Medical Devices & Instruments companies, OraSure Technologies ranks worse than 74.37% on this metric.
The historical rank and industry rank for OraSure Technologies's Days Payable or its related term are showing as below:
OSUR'
s Days Payable Range Over the Past 10 Years
Min: 36.56 Med: 47.29 Max: 71.43
Current: 42.15
During the past 13 years, OraSure Technologies's highest Days Payable was 71.43. The lowest was 36.56. And the median was 47.29.
OSUR's Days Payable is ranked worse than 74.37% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs OSUR: 42.15
OraSure Technologies's Days Payable
increased
from Mar. 2025 (41.38) to Mar. 2026 (48.53).
It may suggest that OraSure Technologiesdelayed paying its suppliers.
OraSure Technologies Days Payable Related Terms
OraSure Technologies Days Payable Historical Data
* Premium members only.
The historical data trend for OraSure Technologies's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, OraSure Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OraSure Technologies Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Days Payable distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
OraSure Technologies's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OraSure Technologies (OSUR) has a Days Payable of 48.53 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OraSure Technologies and its competitors. This is near median its historical median of 47.29. Over the past decade, OraSure Technologies' Days Payable has ranged from 36.56 to 71.43. According to the industry distribution chart, OraSure Technologies ranks #592 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 74.4%.
Is OraSure Technologies' Days Payable too high?
OraSure Technologies' current Days Payable of 48.53 is near median its 10-year median of 47.29. Over the past 10 years, this metric has ranged from a low of 36.56 to a high of 71.43. The Medical Devices & Instruments industry median Days Payable is 68.14. OraSure Technologies' value of 48.53 is 28.8% below this industry median. Based on the distribution chart, OraSure Technologies ranks #592 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, OraSure Technologies has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OraSure Technologies' Days Payable compare to UTMD and SMTI?
According to the Medical Devices & Instruments industry distribution chart, OraSure Technologies ranks #592 out of 796 companies for Days Payable. This places OraSure Technologies in the lower half of its industry. The industry median Days Payable is 68.14. OraSure Technologies' value of 48.53 is 28.8% below this benchmark. Historically, OraSure Technologies' own Days Payable has ranged from 36.56 to 71.43 over the past decade. While the company's 10-year median is 47.29 vs. the industry median of 68.14, OraSure Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OraSure Technologies's current Days Payable of 48.53 is 28.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OraSure Technologies and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OraSure Technologies's current Days Payable is 48.53, which is near median its own 10-year median of 47.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OraSure Technologies stock overvalued right now?
Based on GuruFocus' analysis, OraSure Technologies (OSUR) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.98, compared to a current price of $4.46 — trading 125.3% above its estimated fair value. The current Days Payable is 48.53, which is near median its 10-year median of 47.29 and 28.8% below the Medical Devices & Instruments industry median of 68.14. OraSure Technologies' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For OraSure Technologies (OSUR), the current Days Payable is 48.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OraSure Technologies (OSUR) Overvalued in 2026?
Based on GuruFocus' analysis, OraSure Technologies stock appears to be overvalued.
The current stock price of $4.46 is trading 125.3% above its estimated GF Value™ of $1.98.
GuruFocus considers OraSure Technologies to be Significantly Overvalued.
Key valuation signals for OSUR:
Days Payable: 48.53 (near median its 10-year median of 47.29)
GF Value™: $1.98 vs. price of $4.46 (125.3% above fair value)
Industry Position: 28.8% below the Medical Devices & Instruments median (#592 of 796)
No single metric tells the full story. See the OSUR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
57GF Score
Get the complete analysis for OSUR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSUR has been successfully added to your 
